Compare BOKF & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BOKF | STVN |
|---|---|---|
| Founded | 1910 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Major Banks | Containers/Packaging |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3B | 7.4B |
| IPO Year | N/A | 2021 |
| Metric | BOKF | STVN |
|---|---|---|
| Price | $121.20 | $20.90 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $117.82 | $25.38 |
| AVG Volume (30 Days) | ★ 285.1K | 280.9K |
| Earning Date | 01-16-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.08% | 0.31% |
| EPS Growth | 15.51 | ★ 19.61 |
| EPS | ★ 8.40 | 0.60 |
| Revenue | ★ $2,107,957,000.00 | $1,373,219,524.00 |
| Revenue This Year | $7.26 | $8.42 |
| Revenue Next Year | $6.47 | $9.52 |
| P/E Ratio | ★ $14.42 | $34.86 |
| Revenue Growth | 5.14 | ★ 6.97 |
| 52 Week Low | $85.08 | $17.81 |
| 52 Week High | $122.04 | $28.00 |
| Indicator | BOKF | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 66.83 | 41.86 |
| Support Level | $118.49 | $20.25 |
| Resistance Level | $122.04 | $21.10 |
| Average True Range (ATR) | 2.05 | 0.95 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 79.78 | 17.22 |
BOK Financial Corp is a financial institution in Oklahoma, and it provides a comprehensive range of nationally competitive financial products and services. Its operating segments consist of commercial banking, consumer banking, and wealth management. The company has various products and services, including cash management services, loans and deposits, fiduciary and insurance services, mortgage banking, and brokerage and trading services. It generates maximum revenue from the commercial banking segment. Its commercial banking segment includes lending, treasury and cash management services, and customer risk management products to small businesses, middle market, and larger commercial customers.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.